Efficacy and safety of fluvoxamine for the treatment of COVID-19 patients: A systematic review and meta-analysis

J Infect. 2022 Dec;85(6):702-769. doi: 10.1016/j.jinf.2022.10.012. Epub 2022 Oct 13.
No abstract available

Keywords: COVID-19; Fluvoxamine; SARS-CoV-2; SSRIs.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Letter
  • Comment

MeSH terms

  • COVID-19 Drug Treatment*
  • Fluvoxamine* / adverse effects
  • Humans

Substances

  • Fluvoxamine